.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cannabis and alcohol impairment significantly affects road safety, especially as the consumption of edibles grows in popularity. Simultaneous use of these substances represents a major public health concern for clinicians and emergency responders. Furthermore, controlled data on how oral THC interacts with alcohol have historically been scarce. A recent double-blind crossover trial at the Johns Hopkins University School of Medicine has addressed this gap. The researchers found that combining these substances produces impairment that far exceeds the effects of using either one alone.
Specifically, the study evaluated healthy adults who consumed cannabis-infused brownies and alcohol in a controlled environment. Consequently, the researchers could measure the individual and interactive effects on simulated driving. They utilized the Global Drive Score (GDS) to quantify performance decrements. Notably, the combination of 25 mg of THC with a breath alcohol concentration (BrAC) of 0.05% caused significantly more impairment than alcohol alone at the 0.08% limit. However, the study observed that low-dose THC (10 mg) had a negligible impact when used without alcohol.
In addition, the trial highlighted a major limitation in current roadside detection methods. Moreover, participants often failed simulated driving tasks while still passing Standardized Field Sobriety Tests (SFSTs). This discrepancy suggests that traditional behavioral tests may not effectively identify cannabis and alcohol impairment. Therefore, clinicians must educate patients about the synergistic risks of co-use, as subjective confidence often does not match objective performance. For instance, many participants felt capable of driving despite showing marked deficits in reaction time and lane control.
Thus, these findings suggest that the 0.08% BrAC limit might be too liberal for drivers who also consume cannabis. Because the pharmacokinetic profile of THC remained unchanged by alcohol, the increased impairment likely stems from a pharmacodynamic interaction. Similarly, the public health need for improved impairment detection strategies is now more pressing than ever. Finally, as legalization expands, medical professionals should remain vigilant in counseling patients about the prolonged and unpredictable effects of cannabis edibles.
No, the study results indicated that THC and metabolite pharmacokinetics remained unaffected by alcohol consumption. The increased impairment is likely due to how the substances interact within the central nervous system rather than a change in absorption.
The research suggests they are not fully reliable. Many participants showed significant driving decrements even when they did not exhibit enough clues to fail a standardized field sobriety test.
The study found that driving impairment at the legal limit (0.08% BrAC) was significantly worsened by the addition of cannabis. This suggests that the current legal threshold may not be safe for those who co-use these substances.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Zamarripa CA et al. Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial. JAMA Netw Open. 2026 May 01. doi: 10.1001/jamanetworkopen.2026.9842. PMID: 42065887.
Marcotte TD et al. Can Field Sobriety Tests Identify Drivers Under the Influence of Cannabis? JAMA Psychiatry. 2023;80(10):979–986. doi:10.1001/jamapsychiatry.2023.2345.
National Institute on Drug Abuse (NIDA). Research Reports: Marijuana. National Institutes of Health. Updated 2025.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A crossover trial shows that cannabis edibles and alcohol combined significantly worsen driving impairment compared to using either substance alone....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
